Amgen Submits Sotorasib New Drug Application To U.S. FDA For Advanced Or Metastatic Non-Small Cell Lung Cancer With KRAS G12C Mutation
16 Dec 2020 ... The NDA is being reviewed by the FDA under its Real-Time Oncology Review ( RTOR) pilot program, which aims to explore a more efficient ...